Patent Act P-4
Section 100, as amended by S.C. 2017, c. 6, s. 56
- Earlier version
- In force until June 29, 2021
- Later version
- In force since June 30, 2021 (version in force)
Text deletedText added
Marginal note:Report of Board
Start of deletion Idem End of deletionStart of insertion Contents End of insertion
(2) The report shall contain
(a) a summary of pricing trends in the pharmaceutical industry; and
(b) the name of each Start of deletion patentee End of deletionStart of insertion rights holder and former rights holder End of insertionin respect of whom an order was made under subsection Start of deletion 80 End of deletionStart of insertion 81(1) or 82 End of insertion(2) Start of insertion or section 83 End of insertionduring the year and a statement as to the status of the matter in respect of which the order was made.
Marginal note:Report summary
(3) The summary referred to in paragraph (2)(a) may be based on information and documents provided to the Board by any Start of deletion patentee End of deletionStart of insertion rights holder or former rights holder End of insertionunder section 80, 81 or 82 or in any proceeding under section 83, but shall not be set out in a manner that would make it possible to identify that Start of deletion patentee End of deletionStart of insertion rights holder or former rights holder End of insertion.
Marginal note:Tabling of report
(4) The Minister shall cause a copy of the report to be laid before each House of Parliament on any of the first thirty days on which that House is sitting after the report is submitted to the Minister.
Read the provisionHistory of the ActShow the text in English and French, side by side
Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.